beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Term ID

CHEBI:71355

Synonyms

, O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose
2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
GlcNAcb1-3Galb1-4GlcNAcb
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta
N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine
O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose

Definition

A linear amino trisaccharide comprising N-acetyl-β-D-glucosamine, β-D-galactose and N-acetyl-β-D-glucosamine residues linked sequentially (1→3) and (1→4).

References

glygen:G29487JS
glytoucan:G29487JS
pubmed:19443021
pubmed:25568069
pubmed:31537530
reaxys:8026360

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype where environments contain beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype modified by environments containing beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype affecting beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Human Disease Model